FDA Inspection 1321496 — Haydar A. Frangoul, MD
The FDA completed an inspection of Haydar A. Frangoul, MD on Jun 5, 2026 in Nashville, TN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 5, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Nashville, TN (United States)
Additional Details
Clinical Investigator (CI)